MICHAEL GREENFIELD (BEN ARI)

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

BRAINSTORM CELL THERAPEUTICS INC.

Filing Date Source Excerpt
2006-11-20 Michael Greenfield (Ben Ari) Consists of 100,000 shares of restricted stock, which shares are subject to the Company’s right to repurchase at a purchase price of par value ($0.00005), which repurchase right expires in three (3) equal annual installments beginning on May 27, 2006, and 100,000 shares of restricted stock, which shares are subject to the Company’s right to repurchase at a purchase price of par value ($0.00005), which repurchase right expires in three (3) equal annual installments beginning on May 2, 2007.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22